Vanguard Personalized Indexing Management
ATRC icon

Vanguard Personalized Indexing Management’s AtriCure ATRC Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,635
Closed -$246K – 2254
2026
Q1 		$246K Buy
8,635
+3,277
+61% +$112K ﹤0.01% 1714
2025
Q4 		$212K Buy
+5,358
New +$196K ﹤0.01% 1701
2023
Q4 		– Sell
-8,715
Closed -$382K – 1567
2023
Q3 		$382K Buy
8,715
+2,408
+38% +$117K 0.01% 1017
2023
Q2 		$311K Buy
6,307
+418
+7% +$19.3K 0.01% 1106
2023
Q1 		$244K Sell
5,889
-7,935
-57% -$329K 0.01% 1222
2022
Q4 		$614K Buy
13,824
+8,194
+146% +$342K 0.03% 724
2022
Q3 		$220K Buy
+5,630
New +$258K 0.01% 1075

Other funds holding ATRC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vanguard Personalized Indexing Management's ATRC Position: Q2 2026 in Review

Vanguard Personalized Indexing Management sold out of AtriCure (ATRC) in Q2 2026, closing a stake of 8,635 shares — an estimated $246K sold.

Vanguard Personalized Indexing Management first reported a position in ATRC in Q3 2022 and held it in 7 quarters. The position peaked at $614K in Q4 2022. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Vanguard Personalized Indexing Management reported no remaining AtriCure position as of Q2 2026 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 8,635 AtriCure shares in Q2 2026, an estimated $246K.
  • Vanguard Personalized Indexing Management first reported a position in AtriCure in Q3 2022 and held it in 7 quarters.
  • Vanguard Personalized Indexing Management's AtriCure position peaked at $614K in Q4 2022.
  • 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.